McLeod D T, Ahmad F, Power J T, Calder M A, Seaton A
Br Med J (Clin Res Ed). 1983 Nov 12;287(6403):1446-7. doi: 10.1136/bmj.287.6403.1446.
Over six months Branhamella catarrhalis was isolated in pure culture from the sputum of 81 patients with symptoms of acute respiratory tract infection. Of 38 patients who were infected in the community, over half required admission to hospital. The remaining 43 patients acquired the infection in hospital. Forty one of the 81 isolates produced beta-lactamase, 24 of these being hospital acquired infections. As a result 40% of patients who were treated with ampicillin did not respond. Most patients had chronic lung diseases or lung cancer or were taking corticosteroids. Three patients died and one required assisted ventilation; strains producing beta-lactamase were isolated in each case. Acute bronchitis developed in one previously healthy young non-smoker. It is concluded that B catarrhalis is an important pathogen of the lower respiratory tract which should be reported, and strains producing beta-lactamase should be identified. Otherwise, treatment with inappropriate antibiotics may result in increased morbidity or mortality.
在六个月的时间里,从81例有急性呼吸道感染症状患者的痰液中分离出了纯培养的卡他布兰汉菌。在38例社区感染患者中,超过半数需要住院治疗。其余43例患者在医院获得感染。81株分离菌中有41株产生β-内酰胺酶,其中24株为医院获得性感染。因此,40%接受氨苄西林治疗的患者没有反应。大多数患者患有慢性肺部疾病或肺癌,或者正在服用皮质类固醇。3例患者死亡,1例需要辅助通气;每种情况下均分离出产生β-内酰胺酶的菌株。一名先前健康的年轻不吸烟者患了急性支气管炎。结论是,卡他布兰汉菌是下呼吸道的一种重要病原体,应予以报告,并且应鉴定出产生β-内酰胺酶的菌株。否则,使用不适当的抗生素治疗可能会导致发病率或死亡率增加。